In this live Youtube interview, I had the pleasure of getting to the co-founders (also husband and wife) for 3D Biotechnology Solutions, Ana Millás and Pedro Massaguer. 3DBS is the first Brazilian startup that brought bioprinters to its local research institutions and market, and now it is gearing up to expand its global market including that of the United States. Some of the major talking points of this episode include Ana and Pedro’s early journey as biotech cofounders in Brazil, their funding strategies, market product fit, and their strategies in dealing with the local innovation ecosystem and regulatory agencies. We also dig a little deeper on their new hybrid biofabrication bioprinter that combines electrospinning and extrusion-based bioprinting to generate unique tissue engineering capability for its customers.
Follow our guests:
Key Talking Points:
00:09:40 Talent acquisition strategy
00:11:46 How to get funded
00:21:25 What is Electrospinning?
00:26:12 The Pandemic
About our Guests:
As a biologist, Millás holds her PhD and Master’s degree from the Department of Materials Engineering and Bioprocesses at the School of Chemical Engineering of State University of Campinas/UNICAMP. Post-doctoral degree at School of Pharmaceutical Sciences – University of São Paulo. Ana has made part of her research in internationally renowned research centers and institutions, among them, at Cornell University in the United States and Nottingham Trent University and The Electrospinning Company in UK. She has an amazing experience in the amazon forest, also experience in the textile industry. As the R&I Director at 3D Biotechnology Solutions startup, she focused her research on the development of 3D skin in vitro models, vascularized tissues and cartilage reconstruction using the technologies of electrospinning and 3D bioprinting.
Business Developement, is a specialist in Strategic Business Management. He completed a Master’s and Doctorate in the Science and Technology Policy program at the state University of Campinas (UNICAMP). He has experience in innovative technology-based projects, business development, and strategic planning in the area of Biotechnology. He is the CEO of 3D Biotechnology solutions and also partner of In Situ Cell Therapy and Labtermo Microbiology Consultancy.